Evidence map›Paper›PMID 39048037›Full record

ArticleCellular signalling2024

Effects of heterologous kinase domains on growth factor receptor specificity.

Samantha Y Hayashi, Barbara P Craddock, W Todd Miller

Abstract read
In one paragraph

Article in Cellular signalling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Samantha Y HayashiDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY, USA 11794.
Barbara P CraddockDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY, USA 11794.
W Todd MillerDepartment of Physiology and Biophysics, Stony Brook University, Stony Brook, NY, USA 11794; Department of Veterans Affairs Medical Center, Northport, NY 11768, USA. Electronic address: todd.miller@stonybrook.edu.

Funding

Structural and biochemical studies of receptor tyrosine kinasesI01BX006248 · VA · NORTHPORT VA MEDICAL CENTER · PI W Todd MILLER · 2024 to 2026
–
BLRD VA I01 BX006248
6 · The paper itself

Abstract

The kinase domains of receptor tyrosine kinases (RTKs) are highly conserved, yet they are able to discriminate among potential substrates to selectively activate downstream signaling pathways. In this study, we tested the importance of catalytic domain specificity by creating two series of chimeric RTKs. In one set, the kinase domain of insulin-like growth factor I receptor (IGF1R) was replaced by the kinase domains from insulin receptor (IR), macrophage stimulating protein 1 receptor/Ron (Ron) or Src. In the other set of chimeras, the kinase domain of epidermal growth factor receptor (EGFR) was similarly replaced by the kinase domains of IR, Ron, or Src. We expressed the wild-type and chimeric forms of the receptors in mammalian cells. For some signaling events, such as recognition of IRS1, the identity of the tyrosine kinase catalytic domain did not appear to be crucial. In contrast, recognition of some sites, such as the C-terminal autophosphorylation sites on EGFR, did depend on the identity of the kinase domain. Our data also showed that ligand dependence was lost when the native kinase domains were replaced by Src, suggesting that the identity of the kinase domains could be important for proper receptor regulation. Overall, the results are consistent with the idea that the fidelity of RTK signaling depends on co-localization and targeting with substrates, as well as on the intrinsic specificity of the kinase domain.

Indexed as

Catalytic DomainErbB ReceptorsReceptor, IGF Type 1Recombinant Fusion Proteinssrc Homology DomainsHEK293 CellsMitogen-Activated Protein KinasesMutagenesisPhosphorylationSTAT3 Transcription FactorSubstrate SpecificityEGFR protein, humanErbB ReceptorsIGF1R protein, humanMitogen-Activated Protein KinasesReceptor, IGF Type 1Recombinant Fusion ProteinsSTAT3 Transcription FactorChimeraEGFRIGF1RKinase domainsSpecificityTyrosine kinase

Identifiers

PMID39048037
PMCPMC11707674

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.